文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

BATF 和 IRF4 合作抵抗肿瘤浸润 CAR T 细胞耗竭。

BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.

机构信息

Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.

Novartis Institutes for BioMedical Research, Cambridge, MA, USA.

出版信息

Nat Immunol. 2021 Aug;22(8):983-995. doi: 10.1038/s41590-021-00964-8. Epub 2021 Jul 19.


DOI:10.1038/s41590-021-00964-8
PMID:34282330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8319109/
Abstract

The transcription factors nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1; Fos-Jun) cooperate to promote the effector functions of T cells, but NFAT in the absence of AP-1 imposes a negative feedback program of T cell hyporesponsiveness (exhaustion). Here, we show that basic leucine zipper ATF-like transcription factor (BATF) and interferon regulatory factor 4 (IRF4) cooperate to counter T cell exhaustion in mouse tumor models. Overexpression of BATF in CD8 T cells expressing a chimeric antigen receptor (CAR) promoted the survival and expansion of tumor-infiltrating CAR T cells, increased the production of effector cytokines, decreased the expression of inhibitory receptors and the exhaustion-associated transcription factor TOX and supported the generation of long-lived memory T cells that controlled tumor recurrence. These responses were dependent on BATF-IRF interaction, since cells expressing a BATF variant unable to interact with IRF4 did not survive in tumors and did not effectively delay tumor growth. BATF may improve the antitumor responses of CAR T cells by skewing their phenotypes and transcriptional profiles away from exhaustion and towards increased effector function.

摘要

转录因子活化 T 细胞核因子(NFAT)和激活蛋白 1(AP-1;Fos-Jun)合作促进 T 细胞的效应功能,但 NFAT 在缺乏 AP-1 的情况下会对 T 细胞产生负反馈抑制作用,导致 T 细胞低反应性(耗竭)。在这里,我们发现碱性亮氨酸拉链 AT 样转录因子(BATF)和干扰素调节因子 4(IRF4)在小鼠肿瘤模型中合作以拮抗 T 细胞耗竭。在表达嵌合抗原受体(CAR)的 CD8 T 细胞中过表达 BATF 可促进肿瘤浸润性 CAR T 细胞的存活和扩增,增加效应细胞因子的产生,降低抑制性受体和耗竭相关转录因子 TOX 的表达,并支持产生控制肿瘤复发的长寿命记忆 T 细胞。这些反应依赖于 BATF-IRF 相互作用,因为表达一种不能与 IRF4 相互作用的 BATF 变体的细胞不能在肿瘤中存活,也不能有效地延迟肿瘤生长。BATF 可能通过改变 CAR T 细胞的表型和转录谱,使其从耗竭状态向增强的效应功能倾斜,从而改善抗肿瘤反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/4450524eb6fa/nihms-1707113-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b1fe2ebc6d05/nihms-1707113-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/586f4ab7fd2f/nihms-1707113-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/d50e3facab0f/nihms-1707113-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/ab1ac24d3c83/nihms-1707113-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/3ddc7ef96847/nihms-1707113-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/77c815bdd25f/nihms-1707113-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/a8ccfec5815b/nihms-1707113-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/1bc495e26478/nihms-1707113-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/540364f65e70/nihms-1707113-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b4f6c5a877af/nihms-1707113-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/5ea66004c37b/nihms-1707113-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/5e8b9791570e/nihms-1707113-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/8f22bfb071ae/nihms-1707113-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b81ddd2a992f/nihms-1707113-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/1376c94bc73c/nihms-1707113-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/044edc0f4117/nihms-1707113-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/4450524eb6fa/nihms-1707113-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b1fe2ebc6d05/nihms-1707113-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/586f4ab7fd2f/nihms-1707113-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/d50e3facab0f/nihms-1707113-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/ab1ac24d3c83/nihms-1707113-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/3ddc7ef96847/nihms-1707113-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/77c815bdd25f/nihms-1707113-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/a8ccfec5815b/nihms-1707113-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/1bc495e26478/nihms-1707113-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/540364f65e70/nihms-1707113-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b4f6c5a877af/nihms-1707113-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/5ea66004c37b/nihms-1707113-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/5e8b9791570e/nihms-1707113-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/8f22bfb071ae/nihms-1707113-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/b81ddd2a992f/nihms-1707113-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/1376c94bc73c/nihms-1707113-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/044edc0f4117/nihms-1707113-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a2/8319109/4450524eb6fa/nihms-1707113-f0008.jpg

相似文献

[1]
BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.

Nat Immunol. 2021-8

[2]
TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8 T cell exhaustion.

Proc Natl Acad Sci U S A. 2019-5-31

[3]
NR4A transcription factors limit CAR T cell function in solid tumours.

Nature. 2019-2-27

[4]
BATF-JUN is critical for IRF4-mediated transcription in T cells.

Nature. 2012-9-19

[5]
Transcription Factor IRF4 Promotes CD8 T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection.

Immunity. 2017-12-12

[6]
Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation.

J Cell Physiol. 2021-3

[7]
The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma.

J Allergy Clin Immunol. 2013-11-28

[8]
The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells.

Nat Immunol. 2014-3-2

[9]
-mediated regulation of exhausted CD8 T-cell responses and potential implications for chimeric antigen receptor-T therapy.

Immunotherapy. 2024-3

[10]
Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells.

Cancer Cell. 2022-11-14

引用本文的文献

[1]
Conversion of natural cytokine receptors into orthogonal synthetic biosensors.

Nat Chem Biol. 2025-8-22

[2]
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.

Cancer Cell. 2025-8-18

[3]
Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8 T cell exhaustion-suppressed antitumor immunity.

Sci Adv. 2025-8-15

[4]
The mA-SFRP2-NFAT/TOX axis governs T cell exhaustion in gastric cancer.

Cell Oncol (Dordr). 2025-8-11

[5]
TOX, through a glass, darkly.

Front Immunol. 2025-7-17

[6]
Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering.

JCI Insight. 2025-7-22

[7]
Multimodal delineation of a layer of effector function among exhausted CD8 T cells in tumors.

Sci Immunol. 2025-7-11

[8]
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.

Cell Mol Immunol. 2025-7-10

[9]
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Nat Commun. 2025-7-3

[10]
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review).

Int J Oncol. 2025-7

本文引用的文献

[1]
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.

Nature. 2019-12-11

[2]
c-Jun overexpression in CAR T cells induces exhaustion resistance.

Nature. 2019-12-4

[3]
Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf.

Cell Rep. 2019-10-29

[4]
Defining 'T cell exhaustion'.

Nat Rev Immunol. 2019-9-30

[5]
The ENCODE Blacklist: Identification of Problematic Regions of the Genome.

Sci Rep. 2019-6-27

[6]
Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.

Proc Natl Acad Sci U S A. 2019-6-21

[7]
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.

Nature. 2019-6-17

[8]
TOX is a critical regulator of tumour-specific T cell differentiation.

Nature. 2019-6-17

[9]
TOX transcriptionally and epigenetically programs CD8 T cell exhaustion.

Nature. 2019-6-17

[10]
TOX promotes the exhaustion of antitumor CD8 T cells by preventing PD1 degradation in hepatocellular carcinoma.

J Hepatol. 2019-6-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索